A third party has made a tender offer, or the board has responded to one. This bypasses a shareholder vote, so it can complete far faster than a merger.
| Company | Latest form | Filed | Filings |
|---|---|---|---|
| GBCS (SELECTIS HEALTH, INC.) | SC TO-T/A | 18 August 2026 | 6 |
| Black Pearl Equities LLC | SC TO-T/A | 18 August 2026 | 5 |
| FBRX (Forte Biosciences, Inc.) | SC TO-T/A | 6 August 2026 | 3 |
| DXLG (DESTINATION XL GROUP, INC.) | SC 14D9/A | 6 August 2026 | 4 |
| ARGX (ARGENX SE) | SC TO-T/A | 6 August 2026 | 2 |
| Open Lending Corp | SC TO-T/A | 28 July 2026 | 6 |
| LSTA (LISATA THERAPEUTICS, INC.) | SC TO-T/A | 28 July 2026 | 7 |
| Kuva Labs, Inc. | SC TO-T/A | 28 July 2026 | 3 |
| GNK (GENCO SHIPPING & TRADING LTD) | 425 | 28 July 2026 | 12 |
| DSX (DIANA SHIPPING INC.) | 425 | 28 July 2026 | 9 |
| ANV Group Holdings Ltd. | SC TO-T/A | 28 July 2026 | 3 |
| Camac Fund, LP | SC TO-T/A | 27 July 2026 | 1 |
| Nuvalent, Inc. | SC TO-T/A | 15 July 2026 | 6 |
| GLAXF (GSK plc) | SC TO-T/A | 15 July 2026 | 3 |
From the SEC's quarterly filing index for 2026 QTR3, read 19 August 2026.
Every page is built from the SEC's quarterly filing index, read 19 August 2026. Nothing here is investment advice, and a filing is not an outcome — deals are abandoned, outbid and blocked.